Bevespi Aerosphere - Glycopyrronium with formoterol fumarate
AstraZeneca
Description
Long-acting muscarinic antagonist, Long-acting beta 2 agonist.
Adult: two inhalations twice daily.
Indications
Maintenance treatment of COPD.
Contraindications
Not to be taken in the case of hepatic impairment.
Preparations Available
Inhalation powder
Sizes Available
Inhalation powder
Bevespi Aerosphere 7.2 mcg/5 mcg/dose, 120 doses
More on: Bronchodilators , Compound preparations , Long-acting selective beta2: agonists